Latest filing published 27 Dec 2022 for ABIOMED INC.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Matthew T. Plano: trading record in brief
This profile gathers the share dealings of Matthew T. Plano in Abiomed Inc, where the filings describe the role as senior executive. Between 26 May 2022 and 22 December 2022, the trades on record add up to 11 filings.
No open-market purchase appears, only 4 sales worth €1.4M. Other entries cover 5 share grants and 1 option exercise.
The newest entry dates from 27 December 2022: a transaction, in Abiomed Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Matthew T. Plano
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,406 shares0Common Stock $.01 par valueSEC:0001415889-22-013027:0
- 1,843 shares@ US$223.9066.2% of flowCommon Stock $.01 par valueSEC:0001415889-22-011065:0
- 749 shares@ US$293.3433.8% of flowCommon Stock $.01 par valueSEC:0001415889-22-008542:0
- 2,451 shares0Common Stock $.01 par valueSEC:0001415889-22-005999:0
4 of 4 declarations
